Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-29 Purchase | 2022-05-03 5:49 pm | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner | 2,118,644 | $2.36 | $5,000,000 | 4,295,055 (Indirect) | View |
| 2022-01-07 Purchase | 2022-01-11 6:36 pm | Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President | 2,000 | $4.78 | $9,560 | 113,343 (Direct) | View |
| 2022-01-06 Purchase | 2022-01-10 6:37 pm | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 1,700 | $4.8048 | $8,168 | 1,901 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-03 Option Award | 2023-01-05 8:02 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 69,700 | $0 | 69,700 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:01 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President | 102,700 | $0 | 102,700 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:00 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 177,300 | $0 | 177,300 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:59 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 38,425 | $0 | 38,425 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 7:57 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 20,300 | $0 | 20,300 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-04 08:01 am | N/A 2032-10-02 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 2,500 | $0 | 2,500 (Direct) | View |
Ownership | 2022-10-04 08:00 am | N/A 2032-06-26 | Tempest Therapeutics Inc. | TPST | Trojanowski Justin Corporate Controller | 0 | $0 | 15,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:38 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Lorenzo Pierre Corporate Controller | 8,477 | $0 | 8,477 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:35 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 51,270 | $0 | 51,270 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:32 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 55,680 | $0 | 55,680 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:31 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President | 87,801 | $0 | 87,801 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:29 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 173,533 | $0 | 173,533 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:17 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:16 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:13 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:11 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | Simantov Ronit Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:09 pm | N/A 2032-06-16 | Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director | 3,500 | $0 | 3,500 (Direct) | View |
Ownership | 2022-05-03 5:07 pm | N/A N/A | Tempest Therapeutics Inc. | TPST | Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 0 | $0 | 2,118,644 (Direct) | View |
Ownership | 2022-01-10 5:15 pm | N/A N/A | Tempest Therapeutics Inc. | TPST | Rock Springs Capital Management LP Rock Springs Capital LLC Rock Springs Capital Master Fund LP 10% Owner | 0 | $0 | 823,654 (Indirect) | View |
| 2022-01-04 Option Award | 2022-01-06 7:26 pm | N/A 2032-01-03 | Tempest Therapeutics Inc. | TPST | Lorenzo Pierre Corporate Controller | 6,500 | $0 | 6,500 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 7:26 pm | N/A 2032-01-03 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 19,500 | $0 | 19,500 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 7:25 pm | N/A 2032-01-03 | Tempest Therapeutics Inc. | TPST | Whiting Samuel Chief Medical Officer | 29,000 | $0 | 29,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 7:23 pm | N/A 2032-01-03 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 94,500 | $0 | 94,500 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 7:22 pm | N/A 2032-01-03 | Tempest Therapeutics Inc. | TPST | Dubensky Thomas W. President | 53,100 | $0 | 53,100 (Direct) | View |
| 2021-09-21 Option Award | 2021-09-23 7:56 pm | N/A 2031-09-20 | Tempest Therapeutics Inc. | TPST | RAAB MICHAEL Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-01 Option Award(A) | 2021-09-20 8:34 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | NICHOL GEOFFREY Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-01 Option Award(A) | 2021-09-20 8:29 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Pellizzari Christine A Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-01 Option Award(A) | 2021-09-20 8:13 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-01 Option Award(A) | 2021-09-20 8:10 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Xu Stella Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-08-06 Option Award | 2021-08-10 7:05 pm | N/A 2031-08-05 | Tempest Therapeutics Inc. | TPST | Simantov Ronit Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-12 Option Award | 2021-07-14 4:27 pm | N/A 2031-07-11 | Tempest Therapeutics Inc. | TPST | Maestas Nicholas VP of Strategy and Finance | 23,225 | $0 | 23,225 (Direct) | View |
Ownership | 2021-07-06 6:26 pm | N/A N/A | Tempest Therapeutics Inc. | TPST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Venture Capital IV L.P. Versant Ventures IV LLC Versant Side Fund IV L.P. 10% Owner | 0 | $0 | 2,176,411 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 6:05 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Xu Stella Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 6:01 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Woiwode Thomas Director 10% Owner | 6,635 | $0 | 6,635 (Direct) | View |